Article Correctness Is Author's Responsibility: FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis

The article below may contain offensive and/or incorrect content.

The FDA approval was supported by data from bioavailability studies comparing riluzole tablets and Tiglutik oral suspension.